On November 2, according to Wantai Biotech, recently, the nine-valent HPV vaccine Xinkening® 9, jointly developed by Wantai Biotech's subsidiary Xiamen Wantai Canghai Biotechnology Co., Ltd. and Xiamen University, was officially launched in Thailand. According to data, Citronine® 9 was approved for marketing in China in 2025 and approved by the Thai Food and Drug Administration in 2026. Thailand became its first overseas country to be approved.

On November 2, according to Wantai Biotech, recently, the nine-valent HPV vaccine Xinkening® 9, jointly developed by Wantai Biotech's subsidiary Xiamen Wantai Canghai Biotechnology Co., Ltd. and Xiamen University, was officially launched in Thailand. According to data, Citronine® 9 was approved for marketing in China in 2025 and approved by the Thai Food and Drug Administration in 2026. Thailand became its first overseas country to be approved.